Stem Inc (STEM)

[realfast95]

Video interview

Stem is featured at 28:55

https://www.bloomberg.com/news/videos/2021-05-04/quicktake-take-the-lead-05-03-2021-video

They still continue to mislead on this saving companies 30% narrative.
It's 30% saving on what they had before. Not 30% saving on total electricity.

[realfast95]

previous STEM Holding might be confusing the markets
or just me

0.53 USD +0.020 (3.92%)
May 3, 10:05 AM EDT · Disclaimer
OTCMKTS: STMH

[realfast95]

Form 4 for STPK converting to STEM, Director

[realfast95]

interview STEM energy

https://tdameritradenetwork.com/video/rB4A-HkiEhKBeSQx4TUATg

[realfast95]

it might take a couple of business days for EDGAR to show STEM
I don't know what ihub is asking for for proof.

STEN.com web site is lacking. The cusip number is what we need.
It would be on a trade confirmation but that might a couple of days too.

[Termite7]

Did a merger happen here? Thanks!!!

[Termite7]

Are there multiple tickers named "STEM"....????

[Termite7]

This confuses me!!! .....https://www.otcmarkets.com/stock/STEM/overview

[Termite7]

I was in this in 2009.......





....only I wasn't in it long enough to make very much $$$ !!!!!

[poor500]

$7.00 WOW!!!

[jbaker544]

And there starts the crash of this crappy pumped up stock... Back to penny land!

[lt2211]

That's after the RS only. You need to figure in STEM shareholders get only 5% of existing MBOT shares

[sam1933]

9 STEM will = 1 MBOT

[lt2211]

Read the last paragraph carefully.

Following the completion of the merger and one–for-nine reverse stock split, there are approximately 39 million shares of common stock outstanding. Under the terms of the merger agreement with StemCells, the shareholders of Microbot Medical, and certain advisors and consultants with respect to the merger, received shares of StemCells common stock representing approximately 95% of the outstanding shares of StemCells calculated on a fully diluted basis. Stockholders of StemCells prior to the merger have retained approximately 5% of the company.

[FutureCEO]

I'm definitely waiting to find out. I hold a nice position here.

[Digger 2-0]

The big Question is, how high is the MCAP of the New Stock?

[Digger 2-0]

Microbot Medical Closes Merger Transaction; Initiates Trading on NASDAQ as ‘MBOT’

[Digger 2-0]

So, lets look what will happen today! 7 days to Merger...

[Digger 2-0]

to complete its merger with Microbot on or before November 28, 2016.

[Digger 2-0]

Clay, the dark omen befor Shortattacks! Cover guys and let it go up to 2.++$

[ClayTrader]

* * $STEM Video Chart 11-16-16 * *

Link to Video - click here to watch the technical chart video

[tob999]

The market disagrees with you. I go along with the market's conclusions always thx!

[lt2211]

You aren't one of their investors, in any meaningful way, unless you want to buy the new stock after the merger. Again read the merger agreement, come to your own conclusions.

[CarlCarlMcB]

Lol!!! Make a ton!!!

[tob999]

“We believe both our investors and the market at large will see the potential of Microbot’s robotics platform, specifically its catheter and shunt technologies, and will appreciate Microbot’s overall business opportunities and potential.”

http://ih.advfn.com/p.php?pid=nmona&article=72224041

[lt2211]

Don't believe me, read the merger agreement. No I am not short on A 1:00 stock.

[~ Blue ~]

Cover your one third before!!

[lt2211]

Read up on the nature of reverse mergers, then refer to the merger agreement. A very small percentage of the new shares are set aside for current STEM shareholders.

[tob999]

Once the reverse merger is complete, the stock will be essentially worthless.

And how do you figure that? The MERGER with Microbot could be amazing. Microbot is a private Israeli medical company so you have no idea what value they will be bringing. Your comment is classic shorty ignorance.

Microbot Medical Ltd. is a medical device company that specializes in the research, design, development, and commercialization of micro-robotics assisted medical technologies. Its solutions include ViRob, an autonomous crawling micro-robot that is controlled by electromagnetic fields; TipCAT, a semi-disposable, self-propelled endoscope providing see and treat capabilities; Self-Cleaning Shunt, a robotic system to prevent occlusions in the proximal cerebrospinal fluid shunt system; and TipCAT colonoscope, a self-propelled semi-disposable colonoscope that provides the means to combine technologies, such as high resolution cameras with a self-propelled disposable enclosure

http://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=130942378

[lt2211]

The stock is being pumped for day trading purposes only. Once the reverse merger is complete, the stock will be essentially worthless.

[tob999]

Could be! Huge volume. I grabbed some 1.40's and 1.20's. Wall Str manipulation still unchanged!

[~ Blue ~]

Easy double from this level in my opinion

[~ Blue ~]

true, plus MERGER coming

[tob999]

Big news here Blue..

http://ih.advfn.com/p.php?pid=nmona&article=72923295&symbol=STEM


Item 1.01 Entry into a Material Definitive Agreement.

On November 11, 2016, StemCells, Inc., a Delaware corporation (the "Company"), together with two of its wholly-owned subsidiaries, Stem Cell Sciences Holdings Limited and StemCells California, Inc. (collectively, the "Sellers"), entered into an Asset Purchase Agreement with BOCO Silicon Valley, Inc., a California corporation and wholly-owned subsidiary of Bright Oceans Corporation ("BOCO US").

Pursuant to the terms and subject to the conditions set forth in the Asset Purchase Agreement, the Sellers will sell to BOCO US certain stem and progenitor cell lines that have been researched, studied or manufactured by the Company since 2007 (the "Cell Lines") and certain other tangible and intangible assets, including intellectual property and books and records, related to the foregoing (together with the Cell Lines, the "Assets") in exchange for $4,000,000 in cash, subject to a return of $100,000 to BOCO US if the sale of the Assets (the "Asset Sale") is not completed by December 1, 2016 (the "Asset Consideration"). $300,000 of the Asset Consideration was provided to the Company prior to November 11, 2016 in exchange for the Sellers’ agreement not to solicit or reach any agreement with any third party pertaining to the sale of the Assets. It is anticipated that sixteen former employees of the Company will receive, in aggregate, 15% of the Asset Consideration in accordance with their June 2016 agreements with the Company under which each accepted a more than 50% reduction in his or her severance award otherwise payable. It is also anticipated that, following the completion of the Asset Sale, $400,000 of the Asset Consideration will remain in a twelve-month escrow for the benefit of BOCO US to satisfy certain indemnification obligations of the Sellers which may arise.

The respective boards of directors of the Sellers and BOCO US have approved the Asset Purchase Agreement and the transactions contemplated thereby.

The completion of the Asset Sale is subject to various customary conditions, including, among other things: (a) the completion of the merger of C&RD Israel Ltd., an Israeli corporation and wholly owned subsidiary of the Company, into Microbot Medical Ltd. ("Microbot"), a private medical device company organized under the laws of the State of Israel (the "Microbot Merger"), or, if the Microbot Merger fails to occur as specified in the Asset Purchase Agreement, approval of the Asset Sale by the stockholders of the Company; and (b) subject to certain materiality exceptions, the accuracy of the representations and warranties made by each of the Sellers and BOCO US and the compliance by each of the Sellers and BOCO US with their respective obligations under the Asset Purchase Agreement.

The Asset Purchase Agreement contains customary representations, warranties and covenants, including covenants obligating the Sellers not to sell or abandon the Assets. The Asset Purchase Agreement also contains a customary "no solicitation" provision pursuant to which, prior to the completion of the Asset Sale, the Sellers may not solicit or engage in discussions with any third party regarding another sale of the Assets. The Asset Purchase Agreement also contains certain covenants prohibiting the Sellers from, during the four-year period immediately following the completion of the Asset Sale, (a) engaging in or having any financial interest in a business that is engaged in the research, development or commercialization of the Cell Lines, or (b) soliciting for employment employees of BOCO US. The Asset Purchase Agreement also contains certain termination rights in favor of each of the Sellers and BOCO US.

On November 15, 2016, in order to accommodate remaining pre-closing activities for both the asset sale to BOCO US and the Microbot Merger, the Company, Microbot and C&RD Israel Ltd agreed to extend the Outside Date under their Agreement and Plan of Merger by two weeks, to November 29, 2016. The Company expects to close both the BOCO US and Microbot transactions by the end of November 2016.

Item 8.01 Other Events.

On November 14, 2016, StemCells, Inc. completed its special meeting of stockholders and expects to complete its merger with Microbot on or before November 28, 2016. The special meeting was completed without voting on Proposal 1, which was not presented at the meeting because StemCells has determined, after consulting with its legal counsel, that the proposals approved and adopted by stockholders at the special meeting on October 26, 2016 constitute all stockholder approvals necessary for the transactions contemplated by the merger agreement. Of the proxies submitted for Proposal 1, approximately 96% were voted in favor of the proposal.

http://ih.advfn.com/p.php?pid=nmona&article=72923295&symbol=STEM

[~ Blue ~]

shorts always losing on this stock lol

[FutureCEO]

Ready for a big day today after yesterday's closing!!

[Amikik]

If everybody knows that then it was very easy and simple to make a huge money Bro ... All suspense and inner activities ....... IMO all Technical charts would say

[minten]

they announced they sold their "old" activities for 4 million. considering STEM gets to keep 85% of that, that's 3.5 million. now divide that by the 200+ million shares soon to be outstanding after the Microbot merger, and you'll see this news is worth about 2 cents per share. Why the share price is surging regardless, no idea, it makes no sense.

[FutureCEO]

What caused this after hours surge

[CarlCarlMcB]

News timber

[CarlCarlMcB]

.15

[kingsransome]

so they are about to dilute 200+ million shares,,???

[petermic]

At July 31, 2016, there were 12,006,856 shares of Common Stock, $.01 par value, issued and outstanding.

At October 20, 2016, there were 16,259,598 shares of Common Stock, $.01 par value, issued and outstanding.

As a result of the exchange, the exercise price for all outstanding 2011 Series A warrants and 2016 Series A and Series B warrants has been reset to equal $0.30 per share. The 2016 Series B warrants remain unexercisable pursuant to their terms.

[petermic]

thanks - maybe you've got it right

[stocktraderMNT]

$STEM Day Trading Idea for 11th of November http://stocktradermentor.com/about/scan.htm

[ClayTrader]

* * $STEM Video Chart 11-10-16 * *

Link to Video - click here to watch the technical chart video

[ernie44]

Someone I know sold his laser business

and told me forget about stem cells

[minten]

there are still a nr of warrants left to be exercised at 0.35. i'm guessing the holders and the company want out of them before the merger. so they take up the share price, to dump their shares. it has been the same for months with STEM. just look at how much shares were issued on the last price explosion,

[~ Blue ~]

STEM 52% UP, volume increases

[petermic]

Any idea why it's up so much?